AMRmap - is a web platform for analysis of AMR data in Russia that contains a set of tools to visualize the data on distribution of antimicrobial susceptibilities and main genetic resistance determinants in clinical microbial isolates.
Citation:
- Kuzmenkov AY, Trushin IV, Vinogradova AG, Avramenko AA, Sukhorukova MV, Malhotra-Kumar S, Dekhnich AV, Edelstein MV, Kozlov RS (2021). AMRmap: an interactive web platform for analysis of antimicrobial resistance surveillance data in Russia. Front. Microbiol. 12:620002. doi: 10.3389/fmicb.2021.620002
- Vinogradova A.G., Kuzmenkov A.Yu. Application of AMRmap: «from the general to the specific» approach by the example of Klebsiella pneumoniae. Clinical microbiology and antimicrobial chemotherapy. – 2019. – Vol.21, №2. – P. 181-186. DOI: 10.36488/cmac.2019.2.181-186
The AMRmap database accumulates the data from prospective multicenter AMR surveillance studies conducted by the Institute of Antimicrobial Chemotherapy (IAC) and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC).
Currently, the database contains information on susceptibilities of >55,000 clinical microbial isolates collected in 66 cities of Russia in 1997-2022 and tested at central laboratory of IAC.
Susceptibility categories to antimicrobial agents are determined according to current EUCAST и Russian National Clinical Recommendations on AST.
Press 'Display' each time you change the parameters
The number in each cell indicates the percentage of isolates that are resistant to antibiotic in a column, of the total number of isolates that are resistant to antibiotic in a row.
The trend reflects the proportion of isolates resistant to antibiotic 2 from the total number of isolates that are resistant to antibiotic 1.
The table shows the number and percent of isolates resistant to antibiotic 2 of the total number of isolates resistant to antibiotic 1.
Prevalence of isolates simultaneously resistant to selected antibiotics
This tab shows the total number of isolates carrying specific markers annually collected as part of prospective surveillance as well as isolates referred to the central laboratory for identification or confirmation of particular resistance genotypes.The data for the year 2022 is in the process.
This tab shows the annual prevalence of resistance markers among consecutive isolates collected as part of prospective surveillance.The data for the year 2022 is in the process.
According to data from surveillance studies.
Last data update
- — 25.10.2023
Version
2.4, 27.07.2021
- improved stability of sections;
- performance enhancements.
Archive
2.3, 31.03.2021
- data on serotypes Streptococcus pneumoniae are included;
- design changes in the 'Markers' tab;
- performance enhancements.
2.2, 02.03.2021
- criteria updated EUCAST 2021 (v.11);
- added pwa;
- set color for each marker in the 'Markers' tab;
- added 'screenshot' button with full screen capture;
- added a 'notification' to update the page;
- design changes;
- performance enhancements.
2.1, 14.04.2020
- criteria updated EUCAST (v.10);
- performance enhancements.
2.0, 19.03.2019
- option to create a set of Antibiotics to be displayed under Genetic Resistance Determinants ---> Antibiotics (all);
- added a table in Genetic Resistance Determinants ---> Antibiotics (all);
- added the option to search and analyze associative rules in the Associated Resistance ---> Predictions;
- associative rules are calculated once and stored until a new database update;
- the matrix is calculated once and stored until a new database update;
- the 'Organisms' tab was redesigned: the option of analysis for a selected group of microorganisms was added;
- design changes.
1.9, 12.03.2019
- improved stability of the Comparison section;
- added option to analyze SNP types Pseudomonas aeruginosa;
- accelerated request API snpt.antibiotic.ru;
- MIC trend subsection has been accelerated;
- color stability for different SNP types.
About
Online platform for analysis of AMR data in Russia
Version
2.4 27.07.2021
Aim
Analysis and visualization of antibiotic resistance data
Coordinating organizations
- Inter-regional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC).
- Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU).
Publications
Clinical microbiology and antimicrobial chemotherapy. – 2017. – Vol.19, №2. – P. 84-90.
Clinical microbiology and antimicrobial chemotherapy. – 2019. – Vol.21, №2. – P. 181-186.
Bulletin of Siberian Medicine. – 2020. – Vol.19, №2. – P. 163-170.
Frontiers in Microbiology. 2021; 12: 620002.
Clinical microbiology and antimicrobial chemotherapy. – 2021. – Vol.23, №2. – P. 117-123.
Contacts
The development and administration of AMRmap web platform are supported by the Inter-regional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) and Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU).
The surveillance programs are supported by a group of pharmaceutical companies listed below
2018 year
2017 year
2016 year
Team
Developers
- Alexey Yu. Kuzmenkov, MD, D.Med.Sc. — Author and Lead Developer
- Deputy Director, Institute of Antimicrobial Chemotherapy (IAC)
- Professor at the Department of Microbiology, Smolensk State Medical University (SSMU)
- Alina G. Vinogradova, MD, PhD — Developer
- Senior researcher, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
- Associate Professor at the Department of Microbiology, Smolensk State Medical University (SSMU)
- Ivan V. Trushin — Developer
- Research associate, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
- Andrey A. Avramenko — Developer
- Research associate, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
Consultants
- Roman S. Kozlov, MD, D.Med.Sc., DSc
- Corresponding Member of the Russian Academy of Sciences (RAS)
- Director, Institute of Antimicrobial Chemotherapy (IAC)
- Andrey V. Dehnich, MD, PhD
- Deputy Director, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
- Mikhail V. Edelstein, PhD
- Head, Laboratory of Antimicrobial Resistance, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
